Where I see patients (1)
My reviews
Selected research
-
Targeting high-risk multiple myeloma genotypes with optimized anti-CD70 CAR-T cells.
Blood
-
BCMA-directed CAR T-cell therapy in patients with multiple myeloma and CNS involvement.
Blood advances
-
Daratumumab with lenalidomide as maintenance after transplant in newly diagnosed multiple myeloma: the AURIGA study.
Blood
Clinical trials
A Phase 1b/2 Study of Sonrotoclax (BGB-11417) as Monotherapy and in Various Combinations With D...
DLTs will be based on National Cancer Institute Common Terminology Criteria for Adverse Events (NCI CTCAE) version 5.0 and will include most grade 3 or higher events, as defined in the protocol.
Recruiting
4.9